GlassScriptPhysician profile
Katrina N Masterson
NPI 1164459863
$3,882.38
in general payments reported to CMS, 2019-2025
18 companies · $618 in 2025
The $618 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,302 · 2022: $959 · 2023: $534 · 2024: $469 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.60 |
| Education | $137.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,872.67 | 2021-2025 | |
| Abbvie INC. | $588.00 | 2021-2024 | |
| Janssen Biotech, INC. | $536.88 | 2021-2025 | Tremfya |
| Lilly USA, LLC | $230.86 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $122.83 | 2022-2024 | Sotyktu |
| Ucb, INC. | $110.00 | 2021-2025 | Bimzelx |
| Genzyme Corporation | $107.72 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $73.16 | 2021-2023 | Ilumya |
| Organogenesis INC. | $65.74 | 2022 | |
| Galderma Laboratories, L.P. | $54.40 | 2025 | Nemluvio |
| Leo Pharma INC. | $27.40 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.68 | 2021 | |
| Pfizer INC. | $17.92 | 2022 | |
| Incyte Corporation | $17.84 | 2024 | Opzelura |
| Genentech USA, INC. | $13.79 | 2023 | Erivedge |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11.70 | 2021 | |
| Biofrontera INC. | $10.54 | 2021 | |
| Organon LLC | $1.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Masterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.